Search

Search Constraints

You searched for: Author/Creator Johnson, Terri

Search Results

2. Clinical change 2 years from start of elexacaftor‐tezacaftor‐ivacaftor in severe cystic fibrosis. Issue 4 (27th January 2023)

3. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials. Issue 4 (April 2023)

4. Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index. (March 2020)

5. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. Issue 9 (September 2019)